Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug metabolizing enzymes and their inhibitors' role in cancer resistance

26 May 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Epigenetics and DNA Methylation
Share to Pharmacogenetics and Drug Metabolism

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 29843045
DOI: 10.1016/j.biopha.2018.05.117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 21 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug metabolizing enzymes and their inhibitors' role in cancer resistancePMID 29843045Read ↗

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effectsSemantic proximity Read ↗

Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and OpportunitiesSemantic proximity Read ↗

Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.Semantic proximity Read ↗

Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implicationsSemantic proximity Read ↗

Contributing factors on metabolic mechanism-based CYP3A4-activated/deactivated anticancer drugs: implications for individualizing chemotherapySemantic proximity Read ↗

Activation/Inactivation of Anticancer Drugs by CYP3A4: Influencing Factors for Personalized Cancer TherapySemantic proximity Read ↗

Genetic Polymorphisms of Drug-Metabolising Enzymes and Drug Transporters in the Chemotherapeutic Treatment of CancerSemantic proximity Read ↗

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapySemantic proximity Read ↗

The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative EnzymesSemantic proximity Read ↗

Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.Semantic proximity Read ↗

The clinical role of genetic polymorphisms in drug-metabolizing enzymesSemantic proximity Read ↗

Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug MetabolismSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.